Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Dow
McKesson
AstraZeneca
Merck

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CIPRO Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Cipro patents expire, and what generic alternatives are available?

Cipro is a drug marketed by Bayer Hlthcare, Novartis Pharms Corp, Bayer Pharms, Lupin Ltd, Baxter Hlthcare Corp, Bedford Labs, Dr Reddys, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira, Anchen Pharms, Ani Pharms Inc, Dr Reddys Labs Ltd, Fosun Pharma, Mylan Pharms Inc, Akorn Inc, Altaire Pharms Inc, Amring Pharms, Fdc Ltd, Rising, Rubicon, Teligent, Watson Labs Inc, Aurobindo Pharma, Barr, Carlsbad, Chartwell Molecules, Hikma, Ivax Sub Teva Pharms, Mylan, Nostrum Labs, Pliva, Sun Pharm Inds Ltd, Taro, Teva, Unique Pharm Labs, Watson Labs, Yiling Pharm Ltd, Baxter Hlthcare, Bedford, Inforlife, and Teva Pharms. and is included in fifty-seven NDAs. There are eight patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in CIPRO is ciprofloxacin; dexamethasone. There are thirty-four drug master file entries for this compound. Three suppliers are listed for this compound. There are five tentative approvals for this compound. Additional details are available on the ciprofloxacin; dexamethasone profile page.

Drug patent expirations by year for CIPRO
Drug Prices for CIPRO

See drug prices for CIPRO

Drug Sales Revenue Trends for CIPRO

See drug sales revenues for CIPRO

Recent Litigation for CIPRO

Identify potential future generic entrants

District Court Litigation
Case NameDate
Baker v. Bayer Aktiengescellschaft Corporation2010-04-13
Bayer Schering Pharma AG v. Lupin Ltd.2010-02-18
Bayer Schering Pharma AG v. Lupin Ltd.2010-02-17

See all CIPRO litigation

Pharmacology for CIPRO
Synonyms for CIPRO
1-Cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-[1-piperazinyl)-quinoline-3-carboxylic Acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinoline-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline -3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperzinyl)-3-quinolinecarboxylic acid HCl H2O
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1piperazinyl)-3quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride
3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-
3-Quinolinecarboxylic acid,1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)
3-Quinolinecarboxylicacid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
5E8K9I0O4U
721C331
85721-33-1
A-8526
AB0011928
AB1009412
AC-7613
AC1L1EEW
AJ-08409
AKOS000269653
ALBB-015909
Alcon Cilox
AN-8829
ARONIS020379
AuriPro
Bacquinor
Baflox
BAS 06989041
Bay 09867
Bay o 9867
Bay o 9867 (*Hydrochloride*)
BAY q 3939
Bay-09867
BAY-o 9867
BAY-Q-3939
Baycip
BAYQ3939
BBL005612
BC203729
BCP28586
BDBM21690
Bernoflox
Bi-Cipro
BIDD:GT0205
BPBio1_000140
BRD-K04804440-311-02-3
BRN 3568352
BSPBio_000126
BSPBio_003344
C05349
C17H18FN3O3
CAS-93107-08-5
CBMicro_048498
CCG-39345
CCRIS 5241
Cetraxal
CHEBI:100241
CHEMBL8
Ciflox
Cifloxin
Cilab
Ciloxan
Ciloxan (*Hydrochloride*)
Ciplus
Ciprecu
Ciprine
Ciprinol
Cipro (*Hydrochloride*)
Cipro (TN)
Cipro I.V.
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Cipro IV
Cipro XL
Cipro XR
Ciprobay
Ciprobay Uro
Ciprocinol
Ciprodar
Ciproflox
ciprofloxacin
Ciprofloxacin (Cipro)
Ciprofloxacin (JP17/USP/INN)
Ciprofloxacin [USAN:INN:BAN]
Ciprofloxacin [USAN:USP:INN:BAN]
Ciprofloxacin dihydrochloride
CIPROFLOXACIN EXTENDED RELEASE
Ciprofloxacin Hydrchloride
Ciprofloxacin monohydrochloride
Ciprofloxacin, >=98.0% (HPLC)
Ciprofloxacin, 98%
Ciprofloxacin, Antibiotic for Culture Media Use Only
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard
Ciprofloxacin, VETRANAL(TM), analytical standard
Ciprofloxacin,(S)
Ciprofloxacina
Ciprofloxacine
Ciprofloxacine [INN-French]
Ciprofloxacino
Ciprofloxacino [INN-Spanish]
Ciprofloxacinum
Ciprofloxacinum [INN-Latin]
Ciprogis
Ciprolin
Ciprolon
Cipromycin
Ciproquinol
Ciprowin
Ciproxan
Ciproxin
Ciproxina
Ciproxine
Ciriax
Citopcin
Cixan
Corsacin
CPD000471901
CPF
CPFX
CS-2410
CTK3E8144
Cycin
Cyprobay
D00186
DB00537
DivK1c_000095
DTXSID8022824
Eni
Fimoflox
Flociprin
FT-0601635
HMS1922E18
HMS2090O07
HMS2093I03
HMS500E17
HSDB 6987
HY-B0356
IDI1_000095
Ipiflox
Italnik
J10137
KB-117181
KB-152640
KBio1_000095
KBio2_000642
KBio2_003210
KBio2_005778
KBio3_002846
KBioGR_001567
KBioSS_000642
KS-000002BQ
KS-00004C43
KS-5006
Linhaliq
Linhaliq [Liposomal Formulation]
Loxan
LS-141563
MCULE-8631780654
MFCD00185755
MLS001336035
MLS006011837
MolPort-000-819-654
MYSWGUAQZAJSOK-UHFFFAOYSA-N
NCGC00016959-01
NCGC00016959-02
NCGC00016959-03
NCGC00016959-04
NCGC00016959-05
NCGC00016959-07
NCGC00095058-01
NCGC00095058-02
NCGC00178128-01
NINDS_000095
NSC-758467
NSC620634
NSC758467
Oprea1_008239
Oprea1_313572
Otiprio
Pharmakon1600-01503614
Prestwick0_000113
Prestwick1_000113
Prestwick2_000113
Prestwick3_000113
Probiox
Proflaxin
Proksi 250
Proksi 500
Quinolid
Quintor
Rancif
RKL10073
Roxytal
s2027
SAM002264604
SBB012554
SBI-0048462.P003
SC-17889
SCHEMBL2900
Septicide
SMP1_000125
SMR000471901
Sophixin Ofteno
SPBio_001474
SPBio_002065
Spectrum_000162
SPECTRUM1503614
Spectrum2_001567
Spectrum3_001872
Spectrum4_000874
Spectrum5_001089
Spitacin
SR-05000001863
SR-05000001863-1
SR-05000001863-3
ST024751
ST24046329
STK021082
Superocin
TX-017484
Unex
UNII-5E8K9I0O4U
Velmonit
Velomonit
Z56933707
ZINC20220
Zumaflox

US Patents and Regulatory Information for CIPRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Molecules CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 076896-003 Nov 4, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Inds Ltd CIPROFLOXACIN HYDROCHLORIDE ciprofloxacin hydrochloride TABLET;ORAL 075747-002 Jun 9, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Anchen Pharms CIPROFLOXACIN EXTENDED RELEASE ciprofloxacin; ciprofloxacin hydrochloride TABLET, EXTENDED RELEASE;ORAL 078166-001 Nov 27, 2007 AB RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CIPRO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Hlthcare CIPRO ciprofloxacin FOR SUSPENSION;ORAL 020780-002 Sep 26, 1997   Start Trial   Start Trial
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-004 Oct 22, 1987   Start Trial   Start Trial
Bayer Hlthcare CIPRO ciprofloxacin hydrochloride TABLET;ORAL 019537-003 Oct 22, 1987   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for CIPRO
Drugname Dosage Strength RLD Date
➤ Subscribe Otic Suspension 0.3%/0.1% ➤ Subscribe   Start Trial
➤ Subscribe Oral Suspension 250 mg/5 mL and 500 mg/ 5 mL ➤ Subscribe   Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Express Scripts
Colorcon
Mallinckrodt
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.